ResearchMoz

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Review and Analysis

Publisher Name » GlobalData
Published Date » 2010-10-15
No. Of Pages » 25
Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Review and Analysis

Summary

GlobalDatas Transcatheter Cardiovascular Therapeutics (TCT) 2010: Conference Review and Analysis report is an essentially source of information and analysis on the happenings in the Transcatheter Cardiovascular Therapeutics (TCT) conference held in Washington DC in the US from September 21-25, 2010. The report provides key data and information on the products showcased in the conference. 

The report also provides answers to questions like: what are the emerging trends in the cardiovascular devices market? Which are the upcoming technologies and companies? Which sectors are expected to grow and why? What products are in pipeline and how would they impact sector growth? This report also provides an insight into key studies and trials being held, with up-to date results and analysis.

Scope

  • The report covers information and analysis on product and technology launched at the conference.
  • Analysis and review of the key products and technologies within each segment and sub segments that will impact the future of cardiovascular devices.
  • Review of key industry trends and events which are likely to impact and change the dynamics of the global cardiovascular devices markets in the long run.
  • In-depth analysis of the studies and clinical trials presented at the conference.
  • List of key companies presenting at the conference with company and product profiles.
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global cardiovascular devices market.
  • Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different cardiovascular devices markets.
  • Design and develop your product development, marketing and sales strategies by identifying the market segments poised for a strong growth.
  • Identify key players who are best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • Whats the next being thing in the cardiovascular devices market landscape? Identify, understand and capitalize.
Table of Content

1 Table of Contents 1
1.1 List of Tables 2
1.2 List of Figures 2
2 Summary 3
2.1 Key Takeaways 3

3 Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Highlights 4
3.1 PARTNER Study: All-Cause, Cardiovascular Mortality Lower in Patients Treated with Transcatheter Aortic Valve Implantation (TAVI) versus Standard Therapy at One Year 4
3.2 ABSORB Trial: Bioabsorbable Stents Continue to Demonstrate Strong Clinical Outcomes 6
3.3 Zilver PTX Trial: New Drug Eluting Stent Improves Patency and Safety Outcomes in Patients with Femoropopliteal Artery Disease 7
3.4 Medtronics Resolute Drug Eluting Stent Exhibited Strong Clinical Performance 8
3.5 SPIRIT IV and COMPARE Studies: Xience V Sustains Advantage over Taxus at Two Years 10
3.6 Comparative Effectiveness Research: CYPHER Sirolimus-Eluting Coronary Stent in Patients with Diabetes would Result in Significant Cost Savings Compared to Other Stents 11
3.7 Medtronic Announces Results from IN.PACT Drug-Eluting Balloon (DEB) Clinical Program and Future Clinical Studies 12
3.8 LEVANT I and PERfECT Stent Studies Reiterate Positive Outcomes with Drug-Eluting Balloons 14
3.8.1 LEVANT I Results 14
3.8.2 PERfECT Stent Study Results 15
3.9 TORPEDO Trial: Combined Therapy of Percutaneous Treatment and Anticoagulation Drugs for Deep Venous Thrombosis is Superior to Anticoagulation Drug Therapy Alone 15

4 Key Companies Presentations and their Products 16
4.1 Medtronic 16
4.1.1 Products Presented 16
4.2 St. Jude Medical 17
4.2.1 Product Presented: C7-XR(TM) OCT Intravascular Imaging System 17
4.3 GE Healthcare 17
4.3.1 Product Presented: Innova Vision Technologies 18
4.4 Volcano Corporation 18
4.4.1 Products Presented 18
4.5 Abiomed 19
4.5.1 Products Presented 19
4.6 Neovasc 20
4.6.1 Product Presented: Reducer 20
4.7 InfraReDx 20
4.7.1 Product Presented: LipiScan IVUS Coronary Imaging System 21
4.8 Cook Medical 21
4.8.1 Product Presented: Zilver PTX Drug Eluting Peripheral Stent 21
4.9 Corindus, Inc. 21
4.9.1 Product Presented: CorPath 200 System 22

5 Appendix 23
5.1 Research Methodology 23
5.2 Secondary Research 24
5.3 Primary Research 24
5.4 Models 24
5.5 Forecasts 25
5.6 Expert Panels 25
5.7 GlobalData Consulting 25
5.8 Contact Us 25
5.9 Disclaimer 25

List of Tables


Table 1: Transcatheter Aortic Valves Market, Global, Revenue ($m), 2009 2016 5
Table 2: Coronary Stents Market, Global, Revenue ($bn), 2009 2016 7
Table 3: Drug Eluting Stents Market, Global, Revenue ($bn), 2009 2016 9
Table 4: Drug Eluting Balloons Market, Global, Revenue ($m), 2009 2016 13

List of Figures


Figure 1: Transcatheter Aortic Valves Market, Global, Revenue ($m), 2009 2016 4
Figure 2: Coronary Stents Market, Global, Revenue ($bn), 2009 2016 7
Figure 3: Drug Eluting Stents Market, Global, Revenue ($bn), 2009 2016 9
Figure 4: Drug Eluting Stents Market, Global, Company Share (%), 2009 11
Figure 5: Drug Eluting Balloons Market, Global, Revenue ($m), 2009 2016 13

Upcoming Reports:

Advanced Parenteral Drug Delivery Devices Market - Upcoming Technologies, Current Trends, Global Industry Size, Share, Analysis And Forecast (2012 - 2018)
By - Transparency Market Research
Increasing number of new biological products and emergence of new biosimilars is focusing the attention towards the development of advanced drug delivery technologies for delivery of these biological products. Currently, oral and parenteral drug delivery technologies are dominating the global drug delivery market. Despite various technological innovations and discovery of more compelling and effective methods for drug delivery, parenteral method remains most dominant due to its effective results.   Parenteral drug delivery is one of the largest segments of drug delivery...
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal anti-inflammatory drugs. Although COX-2 is used in treatment of RA, it has several side effects associated with the upper gastrointestinal region.  Currently, use of disease modifying antirheumatic drugs is recommended by most professionals in the early stages of disease. ...
Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

                    

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...